Some of the temporary telehealth flexibilities implemented during the pandemic will soon expire while others have been recently extended. These evolving regulations have hospices concerned that a lack of virtual access to their services could have significant impacts on quality and health disparities. Temporary telehealth flexibilities granted during the pandemic have opened up discussions around […]
Humboldt Center for New Growth
Regulators recently extended certain temporary telemedicine waivers granted during the pandemic, with some flexibilities now sunsetting in 2025 rather than the end of this year. The U.S. Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) have announced the extension of telemedicine flexibilities for the prescribing of controlled medications until […]
Two ketamine-assisted therapy projects are examining ways to develop training and collaboration models for utilization among palliative care patient populations. A growing body of research is uncovering the potential benefits of ketamine therapies to help with symptom management. But greater understanding of the drug and its impacts is needed to help palliative care providers and […]
Telehealth’s value proposition is building in the palliative care realm as regulators mull policies around future utilization, leaving providers to navigate uncertain and potentially difficult challenges among patients. Telehealth has been among the drivers of greater access to palliative care and improved quality among seriously ill patient populations, according to Dr. Michael Fratkin a palliative […]
Palliative care providers may have untapped areas of potential when it comes to improving access and quality through services that address social determinants of health. Though social determinants can take time and resources to build into palliative care programs, they come with a strong return on investment, according to Dr. Yaquta Patni, wound care and […]
Hospice and palliative care providers can benefit from understanding federal and state laws around the use of psychedelics by serious and terminally ill patients. Current regulations govern not only access to these substances, but the research into how patients could be affected. But any rules should include clear federal standards for this research as far […]